Sharpa ranks 11 on the Humanoids 100 with a score of 84; YQ Bionics ranks 36 with 68. Sharpa is ahead on deployment, progress, technology, positioning, firepower and leverage. Level on production and commercials. Sharpa is based in Singapore, Singapore, YQ Bionics in Beijing, China. Sharpa: private. YQ Bionics: private. Sharpa is named in 85 signals and YQ Bionics in 0.
Sharpa sells North, a general-purpose humanoid robot, to enterprise operators for autonomous service and dexterous manipulation.
Darker bar: ahead of the other company on that measure.
Sharpa (Singapore HQ, Shanghai manufacturing) is a self-described unicorn (founded 2024) making the SharpaWave dexterous hand (22 active DoF, >1,000 tactile pixels per fingertip, ~$50,000 per hand) in mass production since October 2025, plus the North full-body robot shown at CES 2026. Its reference-design win is decisive: NVIDIA's Isaac GR00T Reference Humanoid (Computex 2026) is built on a Unitree H2 chassis with Sharpa Wave hands, the first dexterous reference design on the GR00T platform, with lab partners including NVIDIA, Google, MIT, and Stanford. Revenue is estimated at 10-100m (early orders from global technology firms).
85 signals name Sharpa.
78 facts on file.
YQ Bionics manufactures and supplies dexterous robotic hands, a manipulation component for humanoid robots.
Darker bar: ahead of the other company on that measure.
Yuequan Bionics builds dexterous robotic hands on a bionic "tension-compression body" architecture — closer to musculoskeletal loading than conventional linkage hands — and is one of the few hand makers actually in mass production: 36kr reports 10,000 units produced and orders exceeding RMB 100M, alongside financing rounds in the hundreds of millions of yuan (including a Pre-A+). Hands are the acknowledged bottleneck component of the humanoid industry, and a supplier shipping at this volume with real order book is a strategic node: every humanoid maker that does not build hands in-house is a potential customer. This is the strongest components story in the discovered queue.
21 facts on file.
Sharpa ranks 11 on the Humanoids 100 with a score of 84; YQ Bionics ranks 36 with 68. Sharpa is ahead on deployment, progress, technology, positioning, firepower and leverage. Level on production and commercials. Sharpa is based in Singapore, Singapore, YQ Bionics in Beijing, China. Sharpa: private. YQ Bionics: private. Sharpa is named in 85 signals and YQ Bionics in 0.
Sharpa ranks 11 on the Humanoids 100 with a score of 84; YQ Bionics ranks 36 with 68. Sharpa is ahead on deployment, progress, technology, positioning, firepower and leverage. Level on production and commercials. Sharpa is based in Singapore, Singapore, YQ Bionics in Beijing, China. Sharpa: private. YQ Bionics: private. Sharpa is named in 85 signals and YQ Bionics in 0. Both company files carry the scores on eight measures, the facts with sources and the latest signals.
Members see every signal and fact behind both companies, the live ranking, the questions the signals answer and the week explained. $99 a month, 7-day trial. What Frontier Tech Intelligence is →